
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            The endoplasmic reticulum stress-ferroptosis reciprocal signaling orchestrates anti-tumor effect of anlotinib in anaplastic thyroid cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE532E758AF21EA3052E75003076ACEA.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="cancell">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369195/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Cancer Cell International">
<meta name="citation_title" content="The endoplasmic reticulum stress-ferroptosis reciprocal signaling orchestrates anti-tumor effect of anlotinib in anaplastic thyroid cancer">
<meta name="citation_author" content="Yehao Guo">
<meta name="citation_author_institution" content="Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China">
<meta name="citation_author_institution" content="Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Provincial People’s Hospital), Wenzhou, 325000 Zhejiang China">
<meta name="citation_author" content="Juyong Liang">
<meta name="citation_author_institution" content="Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China">
<meta name="citation_author_institution" content="Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China">
<meta name="citation_author_institution" content="Zhejiang Key Laboratory of Precision Medicine Research on Head &amp; Neck Cancer, Hangzhou, 310014 China">
<meta name="citation_author" content="Lingling Ding">
<meta name="citation_author_institution" content="Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China">
<meta name="citation_author" content="Jiajun Wu">
<meta name="citation_author_institution" content="Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China">
<meta name="citation_author" content="Weidong Teng">
<meta name="citation_author_institution" content="Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China">
<meta name="citation_author_institution" content="Hangzhou Normal University, Hangzhou, 311121 Zhejiang China">
<meta name="citation_author" content="Jiafeng Wang">
<meta name="citation_author_institution" content="Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China">
<meta name="citation_author_institution" content="Department of Thyroid and Breast Surgery, Zhejiang Provincial People’s Hospital Bijie Hospital, Bijie, Guizhou, 551700 China">
<meta name="citation_author" content="Liehao Jiang">
<meta name="citation_author_institution" content="Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China">
<meta name="citation_author_institution" content="Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China">
<meta name="citation_author_institution" content="Zhejiang Key Laboratory of Precision Medicine Research on Head &amp; Neck Cancer, Hangzhou, 310014 China">
<meta name="citation_author" content="Zhuo Tan">
<meta name="citation_author_institution" content="Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China">
<meta name="citation_author_institution" content="Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China">
<meta name="citation_author_institution" content="Zhejiang Key Laboratory of Precision Medicine Research on Head &amp; Neck Cancer, Hangzhou, 310014 China">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="25">
<meta name="citation_firstpage" content="310">
<meta name="citation_doi" content="10.1186/s12935-025-03947-z">
<meta name="citation_pmid" content="40841645">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369195/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369195/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369195/pdf/12935_2025_Article_3947.pdf">
<meta name="description" content="Ferroptosis-induced therapy is a promising approach for treating anaplastic thyroid carcinoma (ATC), a highly lethal form of cancer. However, the specific effects of two anti-angiogenic agents, lenvatinib and anlotinib, on ferroptosis in ATC are not ...">
<meta name="og:title" content="The endoplasmic reticulum stress-ferroptosis reciprocal signaling orchestrates anti-tumor effect of anlotinib in anaplastic thyroid cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Ferroptosis-induced therapy is a promising approach for treating anaplastic thyroid carcinoma (ATC), a highly lethal form of cancer. However, the specific effects of two anti-angiogenic agents, lenvatinib and anlotinib, on ferroptosis in ATC are not ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369195/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12369195">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12935-025-03947-z"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12935_2025_Article_3947.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369195%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12369195/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12369195/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369195/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-cancell.png" alt="Cancer Cell International logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Cancer Cell International" title="Link to Cancer Cell International" shape="default" href="https://cancerci.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Cancer Cell Int</button></div>. 2025 Aug 21;25:310. doi: <a href="https://doi.org/10.1186/s12935-025-03947-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12935-025-03947-z</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Cancer%20Cell%20Int%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Cancer%20Cell%20Int%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Cancer%20Cell%20Int%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Cancer%20Cell%20Int%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>The endoplasmic reticulum stress-ferroptosis reciprocal signaling orchestrates anti-tumor effect of anlotinib in anaplastic thyroid cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guo%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Yehao Guo</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Yehao Guo</span></h3>
<div class="p">
<sup>1</sup>Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China </div>
<div class="p">
<sup>4</sup>Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Provincial People’s Hospital), Wenzhou, 325000 Zhejiang China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guo%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yehao Guo</span></a>
</div>
</div>
<sup>1,</sup><sup>4,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Juyong Liang</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Juyong Liang</span></h3>
<div class="p">
<sup>1</sup>Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China </div>
<div class="p">
<sup>2</sup>Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div class="p">
<sup>3</sup>Zhejiang Key Laboratory of Precision Medicine Research on Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Juyong Liang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ding%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Lingling Ding</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Lingling Ding</span></h3>
<div class="p">
<sup>1</sup>Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ding%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lingling Ding</span></a>
</div>
</div>
<sup>1,</sup><sup>#</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Jiajun Wu</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Jiajun Wu</span></h3>
<div class="p">
<sup>2</sup>Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wu%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiajun Wu</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Teng%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Weidong Teng</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Weidong Teng</span></h3>
<div class="p">
<sup>1</sup>Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China </div>
<div class="p">
<sup>5</sup>Hangzhou Normal University, Hangzhou, 311121 Zhejiang China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Teng%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Weidong Teng</span></a>
</div>
</div>
<sup>1,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Jiafeng Wang</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Jiafeng Wang</span></h3>
<div class="p">
<sup>1</sup>Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China </div>
<div class="p">
<sup>6</sup>Department of Thyroid and Breast Surgery, Zhejiang Provincial People’s Hospital Bijie Hospital, Bijie, Guizhou, 551700 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Jiafeng Wang</span></a>
</div>
</div>
<sup>1,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Liehao Jiang</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Liehao Jiang</span></h3>
<div class="p">
<sup>1</sup>Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China </div>
<div class="p">
<sup>2</sup>Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div class="p">
<sup>3</sup>Zhejiang Key Laboratory of Precision Medicine Research on Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Jiang%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Liehao Jiang</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tan%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Zhuo Tan</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Zhuo Tan</span></h3>
<div class="p">
<sup>1</sup>Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China </div>
<div class="p">
<sup>2</sup>Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div class="p">
<sup>3</sup>Zhejiang Key Laboratory of Precision Medicine Research on Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tan%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Zhuo Tan</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>3,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Otolaryngology &amp; Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, 310014 Zhejiang China </div>
<div id="Aff2">
<sup>2</sup>Zhejiang Provincial Clinical Research Center for Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div id="Aff3">
<sup>3</sup>Zhejiang Key Laboratory of Precision Medicine Research on Head &amp; Neck Cancer, Hangzhou, 310014 China </div>
<div id="Aff4">
<sup>4</sup>Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Provincial People’s Hospital), Wenzhou, 325000 Zhejiang China </div>
<div id="Aff5">
<sup>5</sup>Hangzhou Normal University, Hangzhou, 311121 Zhejiang China </div>
<div id="Aff6">
<sup>6</sup>Department of Thyroid and Breast Surgery, Zhejiang Provincial People’s Hospital Bijie Hospital, Bijie, Guizhou, 551700 China </div>
<div class="author-notes p">
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
<div class="fn" id="_eqcntrb93pmc__">
<sup>#</sup><p class="display-inline">Contributed equally.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Feb 4; Accepted 2025 Aug 12; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12369195  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841645/" class="usa-link">40841645</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Ferroptosis-induced therapy is a promising approach for treating anaplastic thyroid carcinoma (ATC), a highly lethal form of cancer. However, the specific effects of two anti-angiogenic agents, lenvatinib and anlotinib, on ferroptosis in ATC are not well understood.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">Methods: To investigate the anticancer activity of lenvatinib and anlotinib in vivo, a subcutaneous tumor model was established in mice. The pharmacological effects of these agents on ATC cells were assessed using various assays, including CCK-8, colony formation, transwell, and sphere-forming assays. Angiogenesis was evaluated using a tubule formation assay. Reactive oxygen species (ROS) levels were measured by flow cytometry, and levels of ferroptosis and endoplasmic reticulum (ER) stress were determined through western blot assays. Immunohistochemistry analyses were used to profile the expression of GPX4, HO-1, PERK, and CHOP in tumor tissues.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Both lenvatinib and anlotinib demonstrated dose- and time-dependent inhibition of Luciferase-8505 C-induced subcutaneous tumors in mice, with anlotinib showing greater efficacy than lenvatinib. In vitro experiments revealed that while both drugs were effective at inhibiting angiogenesis, anlotinib displayed superior antitumor effects in terms of cell viability, proliferation, tumor sphere formation, migration, and invasion. Mechanistic studies indicated that anlotinib induced ROS-mediated ferroptosis through the ER stress pathway, a response not observed with lenvatinib treatment.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusion</h3>
<p id="Par4">Anlotinib showed superior efficacy in treating ATC compared to lenvatinib, independent of their anti-angiogenic properties. The ability of anlotinib to induce ER stress-mediated ferroptosis suggests that targeting ferroptosis may hold promise as a therapeutic strategy for ATC.</p></section><section id="sec5"><h3 class="pmc_sec_title">Graphical Abstract</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369195_12935_2025_3947_Figa_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66c/12369195/b57c56f00b87/12935_2025_3947_Figa_HTML.jpg" loading="lazy" id="MO1" height="815" width="774" alt="graphic file with name 12935_2025_3947_Figa_HTML.jpg"></a></p></section><section id="sec6"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12935-025-03947-z.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Anlotinib, Lenvatinib, Ferroptosis, Endoplasmic reticulum stress, Anaplastic thyroid cancer, Signal pathways.</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par13">Thyroid cancer is the most common endocrine malignancy, with its incidence steadily increasing over the past few decades [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>, <a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>]. Although anaplastic thyroid carcinoma (ATC) accounts for less than 2% of all thyroid cancer cases, it is recognized as the most aggressive subtype, characterized by rapid progression and a median survival of only 5–12 months [<a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>, <a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. Despite the availability of multimodal therapies, including surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy, the clinical outcomes for ATC patients remain dismal due to the disease’s resistance to conventional treatments [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. This dire prognosis underscores the urgent need to identify novel therapeutic strategies to improve survival outcomes in ATC.</p>
<p id="Par14">Recent advancements in cancer biology have highlighted ferroptosis as a promising target for treating therapy-resistant cancers. Unlike apoptosis, ferroptosis is an iron-dependent regulated form of cell death driven by lipid peroxidation, offering a potential strategy to overcome resistance to traditional chemotherapeutics [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Endoplasmic reticulum (ER) stress has been implicated as a key upstream trigger of ferroptosis through the PERK-ATF4-GPX4-ROS signaling pathway [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>]. These mechanistic insights suggest that activating ER stress could provide a novel approach to inducing ferroptosis in ATC.</p>
<p id="Par15">Angiogenesis is another critical driver of ATC progression, and targeting angiogenesis has become a cornerstone of ATC treatment [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>, <a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]. Lenvatinib and anlotinib, two clinically approved anti-angiogenic tyrosine kinase inhibitors (TKIs), have demonstrated efficacy in various malignancies, including thyroid cancer [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. However, as observed in several clinical trials, lenvatinib has shown limited effectiveness in ATC patients, likely due to its inability to address non-angiogenic mechanisms critical for ATC progression [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a>]. On the other hand, emerging evidence indicates that anlotinib inhibits angiogenesis and induces ferroptosis, making it a potentially superior therapeutic option for ATC [<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>, <a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>].</p>
<p id="Par16">Despite these promising findings, the pharmacological differences between lenvatinib and anlotinib in ATC remain poorly understood, particularly regarding their ability to trigger ferroptosis. Therefore, this study aims to systematically compare the anti-tumor mechanisms of lenvatinib and anlotinib, focusing on their capacity to induce ferroptosis via ER stress. Our findings are expected to provide a robust experimental basis for optimizing clinical treatment strategies for ATC.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Reagents and antibodies</h3>
<p id="Par17">Lenvatinib (Cat# E7080) and anlotinib (Cat# AL3818) were obtained from Selleck (USA). Tween 80 (Cat# <a href="https://www.ncbi.nlm.nih.gov/nuccore/T13947" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">T13947</a>), TUDC (Cat# T6993) and PEG300 (Cat# T7022) were sourced from TargetMol (Shanghai, China). HRP-conjugated goat anti-rabbit IgG (#A0208) and goat anti-mouse IgG (#A0216) secondary antibodies were purchased from the Beyotime Institute of Biotechnology (China).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Cell culture and reagents</h3>
<p id="Par18">Human thyroid epithelial cells (Nthy-ori 3 − 1), papillary thyroid carcinoma (PTC) cell lines (TPC-1 and IHH4), and anaplastic thyroid carcinoma (ATC) cell lines (8505 C, KHM-5 M, Hth-7, C643, CAL-62, and BHT101) were obtained from certified cell repositories, including Procell Life Science &amp; Technology (Wuhan, China), DSMZ (Germany), and the National Collection of Authenticated Cell Cultures (Shanghai, China). Cell lines were authenticated using STR profiling and cultured in RPMI-1640 medium (HyClone) supplemented with 10% fetal bovine serum (FBS, Cat# S-FBS-SA-015, SERANA, Germany), 100 U/mL penicillin, and 0.1 mg/mL streptomycin. Cultures were maintained at 37 °C in a humidified atmosphere with 5% CO₂.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Cell viability assay</h3>
<p id="Par19">The cytotoxic effects of lenvatinib and anlotinib were evaluated using the CCK-8 assay (Cat# A311-01; Vazyme Biotech, China). Cells (4,000 per well) were seeded in 96-well plates and treated with anlotinib (0, 2, 4, 8, 16, and 32 µM) or lenvatinib (0, 2, 4, 8, 16, 32, and 64 µM) for 24, 48, or 72 h. After incubation with CCK-8 solution at 37 °C for 2 h, absorbance at 450 nm was measured using a Synergy LX Multi-Mode Reader (BioTek Instruments, USA).</p></section><section id="Sec6"><h3 class="pmc_sec_title">Colony formation assay</h3>
<p id="Par20">ATC cells (8505 C and KHM-5 M; 1,000 per well) were seeded in 6-well plates and incubated at 37 °C with 5% CO₂ for 24 h. Detached cells were removed by washing three times with PBS, and cells were treated with anlotinib or lenvatinib (0, 2, 4, 8, 16, and 32 µM). After one week, colonies were fixed with 4% paraformaldehyde for 30 min and stained with 0.5% crystal violet for 30 min. Colony counts were quantified using ImageJ software.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Transwell migration and invasion assays</h3>
<p id="Par21">Transwell chambers (Corning, USA) were used to assess cell migration and invasion. For migration, 3 × 10<sup>4</sup> cells were seeded in the upper chamber with serum-free medium, while the lower chamber contained medium with 10% FBS and varying concentrations of anlotinib or lenvatinib (0, 2, 4, 8, and 16 µM). For invasion assays, chambers were pre-coated with Matrigel (1:4 dilution; BD Biosciences) for 1 h. After 24 h (migration) or 48 h (invasion) at 37 °C, cells were fixed with 4% paraformaldehyde and stained with 0.01% crystal violet. Migrated and invaded cells were counted using ImageJ software.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Sphere formation assay</h3>
<p id="Par22">8505 C and KHM-5 M cells were seeded in ultra-low attachment 6-well plates (Corning, USA) and cultured in DMEM/F12 medium supplemented with B27, 20 ng/mL EGF, and 20 ng/mL bFGF. Anlotinib and lenvatinib (0, 2, 4, and 8 µM) were added, and spheres were imaged under a microscope after one week.</p></section><section id="Sec9"><h3 class="pmc_sec_title">Tube formation assay</h3>
<p id="Par23">Matrigel (BD Biosciences; diluted 1:2) was added to 96-well plates and solidified at 37 °C for 30–60 min. HUVECs (1.5–3 × 10<sup>4</sup> cells per well) were suspended in a conditioned medium containing lenvatinib or anlotinib (0, 2, and 4 µM) and seeded onto the solidified Matrigel. Tube formation was imaged at 3, 6, and 12 h using an inverted microscope.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Intracellular ROS and lipid peroxidation assays</h3>
<p id="Par24">Cells were treated with anlotinib or lenvatinib for 24 h, then stained with DCFH-DA (10 µM, Cat# <a href="https://www.ncbi.nlm.nih.gov/nuccore/T15458" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">T15458</a>, TargetMol) or C11 BODIPY 581/591 (20 µM, Cat# D3861, Thermo Fisher) in the dark for 30 min. After washing with PBS, ROS and lipid peroxidation levels were analyzed by flow cytometry (NovoCyte Advanteon, Agilent, USA).</p></section><section id="Sec11"><h3 class="pmc_sec_title">Western blot analysis</h3>
<p id="Par25">Cell lysates were prepared using a lysis buffer containing PMSF. Protein concentrations were determined using a BCA kit (Thermo Fisher). SDS-PAGE separated equal protein amounts, transferred to PVDF membranes, and blocked with 5% skim milk. Membranes were incubated overnight with primary antibodies, followed by HRP-conjugated secondary antibodies. Signals were visualized using a ChemiDoc-MP imager (Bio-Rad). Band intensities were analyzed using ImageJ.</p>
<p id="Par26">Primary antibodies included rabbit anti-TFR (A19130, 1:5000), rabbit anti-FTH1 (A19544, 1:5000), rabbit anti-FTL (A11241, 1:5000), and HRP-conjugated β-Tubulin mouse mAb (AC030, 1:10000) from ABclonal, China; rabbit anti-HO-1 (10701-AP, 1:2000), rabbit anti-CHOP (15204-AP, 1:1000), and rabbit anti-ATF4 (10835-AP, 1:1000) from Proteintech, USA; rabbit anti-GPX4 (ab125066, 1:5000) from Abcam, USA; rabbit anti-PERK (#5683, 1:1000), rabbit anti-BiP (#3177, 1:1000), and rabbit anti-phospho-eIF2α (#3597, 1:1000) from Cell Signaling Technology, USA; and rabbit anti-eIF2α (AF6087, 1:1000) from Affinity, USA. Mouse anti-4HNE (ab48506, 1:25) from Abcam, USA. HRP-conjugated goat anti-rabbit (Cat#: A0208) and anti-mouse (Cat#: A0216) IgG secondary antibodies were from Beyotime Institute of Biotechnology, China.</p></section><section id="Sec12"><h3 class="pmc_sec_title">In vivo xenograft tumor model</h3>
<p id="Par27">Female BALB/c nude mice (3–4 weeks old) were subcutaneously injected with luciferase-expressing 8505 C cells (5 × 10<sup>6</sup> cells/100 µL). Once tumors reached ~ 60 mm<sup>3</sup>, mice were randomized into five groups (<em>n</em> = 5) and treated with lenvatinib or anlotinib (2 or 4 mg/kg, i.p.) daily. Tumor growth and body weight were monitored. Bioluminescence imaging was conducted every five days using an IVIS Lumina III spectrometer. After 15 days, mice were euthanized, and tumors and organs were collected for histological and biochemical analysis. All animal experiments were approved by the Animal Care and Use Committee of Zhejiang Provincial People’s Hospital (Approval No. 20231205163258888328).</p></section><section id="Sec13"><h3 class="pmc_sec_title">Immunohistochemical staining</h3>
<p id="Par28">Paraffin-embedded tumor sections were deparaffinized, rehydrated, and subjected to antigen retrieval using citrate buffer (pH 6.0). After blocking with 3% BSA, sections were incubated with primary antibodies, followed by HRP-conjugated secondary antibodies. Positive signals were visualized using 3,3′-diaminobenzidine, and images were captured with a fluorescence microscope.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par29">Statistical analyses were performed using GraphPad Prism 9. Differences between groups were analyzed using one-way or two-way ANOVA or t-tests. Data are presented as mean ± SD (<em>n</em> = 3), and statistical significance was defined as <em>P</em> &lt; 0.05.</p></section></section><section id="Sec15"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec16"><h3 class="pmc_sec_title">Pharmacological and toxicological comparison between lenvatinib and anlotinib in ATC</h3>
<p id="Par30">In vivo, imaging of tumor-bearing mice revealed that both lenvatinib and anlotinib significantly inhibited tumor growth in a dose- and time-dependent manner compared to the control group (Fig. <a href="#Fig1" class="usa-link">1</a>A-D). Hematoxylin and eosin (HE) staining of tumor tissues showed Consistent with the tumor growth suppression, H&amp;E staining of excised tumors (Supplementary Fig. <a href="#Fig1" class="usa-link">1</a>) revealed extensive necrosis in the treatment group compared to controls, further supporting the efficacy of anlotinib. reduced tumor cell density in the treatment groups, with the lowest density observed in the anlotinib 4 mg/kg group (Supplementary Fig. <a href="#Fig1" class="usa-link">1</a>). Notably, at equivalent doses (2 mg/kg and 4 mg/kg), anlotinib demonstrated superior tumor inhibition, as evidenced by reduced tumor volumes and enhanced histological outcomes.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369195_12935_2025_3947_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66c/12369195/08e8b31abc62/12935_2025_3947_Fig1_HTML.jpg" loading="lazy" id="MO2" height="671" width="669" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Lenvatinib and anlotinib inhibit the proliferation of luciferase-expressing 8505 C (Luciferase-8505 C) cell xenografts in vivo. (<strong>A</strong>) Representative images of Luciferase-8505 C xenograft tumors in BALB/c nude mice treated with Lenvatinib (2 mg/kg and 4 mg/kg, intraperitoneally; <em>n</em> = 5 per group) and anlotinib (2 mg/kg and 4 mg/kg, intraperitoneally; <em>n</em> = 5 per group). Tumor volumes were measured every 5 days. (<strong>B</strong>) Growth curves of xenograft tumor volumes, measured every other day, are shown as mean ± SD. (<strong>C</strong>) Macroscopic views of xenograft tumors at the experimental endpoint. Tumors were derived from Luciferase-8505 C cells. (<strong>D</strong>) Average tumor weights from each group were calculated and are presented as mean ± SD (<em>n</em> = 5). (<strong>E</strong>) Animal body weights were measured every other day and are displayed as mean ± SD (<em>n</em> = 5). For comparisons, Student’s t test was performed; ns <em>p</em> &gt; 0.05, *<em>p</em> &lt; 0. 05, **<em>p</em> &lt; 0. 01</p></figcaption></figure><p id="Par31">No significant changes in body weight were observed across all treatment groups, indicating a favorable safety profile for both drugs (Fig. <a href="#Fig1" class="usa-link">1</a>E). Similarly, HE staining of heart, liver, and kidney tissues revealed no pathological changes, and biochemical analyses of liver and kidney function (e.g., ALT, AST, BUN, ALP, UA, CR, ALB) showed no significant differences compared to controls (Supplementary Figs. <a href="#Fig1" class="usa-link">1</a> and <a href="#Fig2" class="usa-link">2</a>). These findings suggest that while both drugs exhibit acceptable safety, anlotinib outperforms lenvatinib in inhibiting ATC tumor growth, potentially due to their distinct pharmacological mechanisms.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369195_12935_2025_3947_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66c/12369195/a134403a8c77/12935_2025_3947_Fig2_HTML.jpg" loading="lazy" id="MO3" height="1016" width="776" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Lenvatinib and anlotinib differ in their ability to inhibit angiogenesis and cell viability in human normal thyroid, PTC, and ATC cells. Representative images were quantified using ImageJ (<em>n</em> = 3). (<strong>A</strong>) Primary HUVECs were seeded, and after 6 h, Lenvatinib and anlotinib (0, 2, 4 µM) were added. Images were collected at 3, 6, and 12 h using light microscopy. (<strong>B</strong>) Nthy-ori 3 − 1, 8505 C, and KHM-5 M cells were exposed to varying concentrations of lenvatinib (0, 4, 8, 16, 32, 64 µM) and anlotinib (0, 2, 4, 8, 16, 32 µM) for 24, 48, and 72 h. Cell viability was assessed using the CCK-8 assay. (<strong>C</strong>) Nthy-ori 3 − 1, TPC-1, IHH4, CAL-62, C643, BHT101, 8505 C, KHM-5 M, and Hth-7 were similarly treated, and IC50 values were calculated using non-linear regression analysis with GraphPad Prism 9. ns <em>p</em> &gt; 0.05, *<em>p</em> &lt; 0. 05, **<em>p</em> &lt; 0. 01</p></figcaption></figure></section><section id="Sec17"><h3 class="pmc_sec_title">Distinct cellular effects of lenvatinib and anlotinib</h3>
<p id="Par33">Both lenvatinib and anlotinib are recognized angiogenesis inhibitors [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>, <a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>]. Consistent with this, our results showed that both drugs significantly inhibited the angiogenic potential of vascular endothelial cells, with no significant differences between them across varying concentrations and time points (Fig. <a href="#Fig2" class="usa-link">2</a>A). These data suggest that the differential anti-tumor efficacy of lenvatinib and anlotinib is unlikely attributable to their anti-angiogenic activity.</p>
<p id="Par34">We next evaluated the cytotoxic effects of the two drugs on normal thyroid cells, papillary thyroid carcinoma (PTC) cells, and ATC cells. The IC₅₀ values revealed that while both drugs exhibited anti-ATC activity, anlotinib demonstrated significantly higher cytotoxicity than lenvatinib (Fig. <a href="#Fig2" class="usa-link">2</a>B, Supplementary Fig. <a href="#Fig3" class="usa-link">3</a>). Notably, both drugs exhibited higher cytotoxicity in tumor cells than in normal thyroid cells, highlighting their tumor-specific effects (Fig. <a href="#Fig2" class="usa-link">2</a>C).</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369195_12935_2025_3947_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66c/12369195/07b6ae11059e/12935_2025_3947_Fig3_HTML.jpg" loading="lazy" id="MO4" height="621" width="669" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Lenvatinib and anlotinib inhibit colony formation and tumor stemness of human ATC cells. (<strong>A</strong>) Representative images of 8505 C and KHM-5 M colony formation at the indicated concentrations were quantified using ImageJ (<em>n</em> = 3). (<strong>B</strong>) 8505 C and KHM-5 M cells spheroid were imaged under a microscope. Data are presented as mean ± SD (<em>n</em> = 3). ns <em>p</em> &gt; 0.05, *<em>p</em> &lt; 0. 05, **<em>p</em> &lt; 0. 01</p></figcaption></figure><p id="Par36">Further functional assays revealed that both lenvatinib and anlotinib inhibited colony formation, migration, invasion, and sphere formation in 8505 C and KHM-5 M cells in a dose-dependent manner (Figs. <a href="#Fig3" class="usa-link">3</a>A-B and <a href="#Fig4" class="usa-link">4</a>A-B). However, at higher concentrations (&gt; 2 µM), anlotinib consistently showed superior anti-tumor activity compared to lenvatinib. These in vitro findings align with our in vivo observations, further emphasizing the distinct pharmacological advantages of anlotinib.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369195_12935_2025_3947_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66c/12369195/2fcf344969c2/12935_2025_3947_Fig4_HTML.jpg" loading="lazy" id="MO5" height="790" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Anlotinib suppresses ATC cell migration and invasion. Lenvatinib and anlotinib differ significantly in their inhibitory effects. (<strong>A</strong>) Migration assays showed that both agents reduced the migratory capacity of KHM-5 M and 8505 C cells in a dose-dependent manner. (<strong>B</strong>) Invasion assays demonstrated that both drugs inhibited cell invasion. Histograms depict the number of invasive cells, with data presented as mean ± SD (<em>n</em> = 3). ns <em>p</em> &gt; 0.05, *<em>p</em> &lt; 0. 05, **<em>p</em> &lt; 0. 01</p></figcaption></figure></section><section id="Sec18"><h3 class="pmc_sec_title">Ferroptosis in ATC cells induced by anlotinib but not lenvatinib</h3>
<p id="Par39">We previously demonstrated that anlotinib could trigger ferroptosis in ATC cells [<a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. We measured intracellular reactive oxygen species (ROS) and lipid ROS levels to elucidate the underlying mechanisms. Both drugs induced dose-dependent increases in ROS and lipid ROS levels; however, anlotinib consistently induced higher levels of both markers than lenvatinib at equivalent concentrations (Fig. <a href="#Fig5" class="usa-link">5</a>A-B).</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369195_12935_2025_3947_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66c/12369195/55742188211a/12935_2025_3947_Fig5_HTML.jpg" loading="lazy" id="MO6" height="1016" width="743" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Lenvatinib and anlotinib inhibit tumor growth and promote ferroptosis in ATC cells by enhancing ROS generation. (<strong>A</strong>) ATC cells 8505 C and KHM-5 M were treated with lenvatinib and anlotinib (0, 4, 8, and 16 µM) for 24 h. After incubation in the dark for 30 min with 10 µM DCFH-DA probe, ROS levels were assessed using flow cytometry. (<strong>B</strong>) ATC cells 8505 C and KHM-5 M were treated with lenvatinib and anlotinib (0, 5 and 10 µM) for 24 h. After incubation in the dark for 30 min with 20 µM C11 Bodipy 581/591 probe, lipid ROS levels were assessed using flow cytometry. (<strong>C</strong>) Western blot was used to measure TFR, FTL, GPX4, HO-1 and FTH1 protein levels in 8505 C and KHM-5 M cells, after lenvatinib and anlotinib (0, 5, 10 µM) treatment for 24 h. (<strong>D</strong>) Western blot was used to measure GPX4, HO-1 protein levels in 8505 C and KHM-5 M cells, after lenvatinib and anlotinib (0, 4, 8, 12 µM) treatment for 24 h. For comparisons, Student’s t test was performed; Data are shown as mean ± SD (<em>n</em> = 3). ns <em>p</em> &gt; 0.05, *<em>p</em> &lt; 0. 05, **<em>p</em> &lt; 0. 01</p></figcaption></figure><p id="Par40">Western blot analysis further revealed that anlotinib downregulated ferroptosis-associated proteins, including TFR, FTL, GPX4, and FTH, while upregulating HO-1 expression dose-dependently. In contrast, lenvatinib did not induce significant changes in the expression of these proteins (Fig. <a href="#Fig5" class="usa-link">5</a>C). Additionally, in ATC cells (8505 C and KHM-5 M), we treated the cells with lenvatinib (5 µM) and anlotinib (5 µM) at 0 h, 4 h, and 8 h, followed by Western blot analysis of ferroptosis-related markers GPX4 and HO-1 protein levels. We found that lenvatinib had no significant effect on the protein levels of ferroptosis markers, while anlotinib induced a time-dependent downregulation of GPX4 and a time-dependent upregulation of HO-1 protein levels, which was consistent with the results from our animal experiments (Fig. <a href="#Fig5" class="usa-link">5</a>D). These findings suggest that anlotinib effectively induces ferroptosis in ATC cells and exhibits both time- and concentration-dependent effects, a mechanism absent with lenvatinib treatment.</p></section><section id="Sec19"><h3 class="pmc_sec_title">Differential ER stress responses contribute to variability in ferroptosis induction</h3>
<p id="Par42">We examined the expression of ER stress-related proteins to investigate why anlotinib induces ferroptosis while lenvatinib does not. In 8505 C and KHM-5 M cells treated with lenvatinib, ER stress markers such as ATF4, BiP, CHOP, and p-eIF2α remained unchanged. In contrast, although the level of PERK was downregulated and eIF2α levels remained unchanged, anlotinib treatment significantly upregulated these markers (Fig. <a href="#Fig6" class="usa-link">6</a>A). Furthermore, in ATC cells (8505 C and KHM-5 M), we treated the cells with lenvatinib (5 µM) and anlotinib (5 µM) at 0 h, 4 h, and 8 h, followed by Western blot analysis of BiP and CHOP protein levels. We found that lenvatinib had no significant effect on ER stress, while anlotinib induced a time-dependent upregulation of BiP and CHOP protein levels, consistent with our animal experiment results (Fig. <a href="#Fig6" class="usa-link">6</a>B).</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369195_12935_2025_3947_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66c/12369195/9f84b1766062/12935_2025_3947_Fig6_HTML.jpg" loading="lazy" id="MO7" height="685" width="669" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Effects of lenvatinib and anlotinib on protein expression in ATC cells and xenograft tumors. (<strong>A</strong>) Western blot analysis of PERK, ATF4, BIP, ELF2A, P-ELF2A, and CHOP in ATC cells treated with lenvatinib and anlotinib (0, 5, 10 µM) for 24 h. (<strong>B</strong>) Western blot was used to measure GPX4, HO-1 protein levels in 8505 C and KHM-5 M cells, after lenvatinib and anlotinib (0, 4, 8, 12 µM) treatment for 24 h. (<strong>C</strong>) 8505 C and KHM-5 M cells were treated with anlotinib, with or without TUDC (20 µM), for 24 h. Western blot analysis was performed to detect the expression levels of GPX4, HO-1, BiP, and CHOP. For comparisons, Student’s t test was performed; Data are shown as mean ± SD (<em>n</em> = 3). ns <em>p</em> &gt; 0.05, *<em>p</em> &lt; 0. 05, **<em>p</em> &lt; 0. 01</p></figcaption></figure><p id="Par43">To further validate the role of anlotinib in inducing endoplasmic reticulum (ER) stress in thyroid cancer (ATC) cells, we conducted experiments using the ER stress activator TUDC. The ATC cells were divided into four groups: a control group, an anlotinib monotherapy group, an ER stress activator TUDC group, along with a combined treatment group (anlotinib with TUDC). Through Western blot analysis, we observed the following results: after treating the ATC cells (8505 C and KHM-5 M) with TUDC (20 µM) for 24 h, the protein level of GPX4 was downregulated, while the protein expression levels of HO-1, BiP, and CHOP were upregulated. Furthermore, after the combined treatment of anlotinib (5 µM) with TUDC, Western blot results showed that the group receiving anlotinib combined with TUDC exhibited a greater downregulation of GPX4 protein levels and upregulation of HO-1, BiP, and CHOP protein levels compared to the group receiving anlotinib alone. These results suggest that anlotinib may promote ferroptosis in ATC cells by increasing CHOP-mediated ER stress and depleting GPX4, potentially enhancing tumor cell death through this mechanism (Fig. <a href="#Fig6" class="usa-link">6</a>C).</p>
<p id="Par44">Immunohistochemical analysis of xenograft tumor samples confirmed these findings, showing increased expression of ER stress-related proteins and ferroptosis markers in the anlotinib-treated group (Fig. <a href="#Fig7" class="usa-link">7</a>). Together, these results indicate that anlotinib induces ER stress, critical in triggering ferroptosis in ATC cells. In contrast, lenvatinib does not elicit a similar response, highlighting a key mechanistic difference between the two drugs.</p>
<figure class="fig xbox font-sm" id="Fig7"><h4 class="obj_head">Fig. 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12369195_12935_2025_3947_Fig7_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e66c/12369195/e89525c3d570/12935_2025_3947_Fig7_HTML.jpg" loading="lazy" id="MO8" height="684" width="669" alt="Fig. 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig7/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Expression levels of Ki67, GPX4, HO-1, BiP, CHOP and 4-HNE in xenograft tumors were assessed using IHC staining. Data are shown as mean ± SD (<em>n</em> = 3). ns <em>p</em> &gt; 0.05, *<em>p</em> &lt; 0. 05, **<em>p</em> &lt; 0. 01</p></figcaption></figure></section></section><section id="Sec20"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par47">Anaplastic thyroid carcinoma (ATC) progresses rapidly and has the poorest prognosis among thyroid malignancies, with a significant proportion of patients presenting with advanced disease at diagnosis [<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. Systemic treatment response rates remain below 15%, underscoring the urgent need for novel therapeutic strategies to improve survival outcomes in ATC patients [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]. Current first-line treatments, including doxorubicin, cisplatin, and sorafenib, have shown limited efficacy, often due to the activation of compensatory angiogenesis, which undermines therapeutic success [<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Consequently, targeting angiogenesis has become a cornerstone of ATC therapy [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>].</p>
<p id="Par48">TKIs can alter the metabolism and iron homeostasis within tumor cells, potentially affecting the activity of immune cells in the tumor microenvironment and inducing immune responses [<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>]. The combination with ferroptosis inducers may further modulate the tumor immune environment and enhance the efficacy of immunotherapy. Multi-target TKIs can change the tumor microenvironment by inhibiting tumor cell proliferation and suppressing angiogenesis, which may lead to alterations in iron homeostasis and promote ferroptosis [<a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>]. For example, sorafenib, by inhibiting signaling pathways like VEGFR and PDGFR, could result in the accumulation of iron ions within tumor cells, creating conditions conducive to ferroptosis. When combined with ferroptosis inducers, it can alter the metabolism and iron homeostasis within tumor cells, potentially influencing the activity of immune cells in the tumor microenvironment, further inducing immune responses and improving the effectiveness of immunotherapy [<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a>].</p>
<p id="Par49">Among anti-angiogenic therapies, lenvatinib and anlotinib are TKIs with significant efficacy in treating various malignancies, including ATC [<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>]. While lenvatinib has demonstrated some success in clinical trials, its therapeutic effects in unresectable ATC remain suboptimal [<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. Conversely, anlotinib has shown potent anti-tumor activity across multiple cancer types, yet its mechanisms of action are not fully elucidated. Our study provides evidence that anlotinib exhibits superior efficacy compared to lenvatinib in inhibiting ATC growth in vitro and in vivo.</p>
<p id="Par50">Ferroptosis, an iron-dependent form of regulated cell death characterized by lipid peroxidation and reactive oxygen species (ROS) accumulation, has emerged as a promising therapeutic target for cancer [<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Recent studies have shown that RAS-mutant cancer cells, which are highly prevalent in ATC (10–50% of cases), exhibit increased susceptibility to ferroptosis [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>–<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. Additionally, dedifferentiated and apoptosis-resistant cancer cells, common in advanced ATC, are more sensitive to ferroptosis, further underscoring its therapeutic potential [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>]. Recent studies have suggested that there may be an interaction between ferroptosis and ER stress in various cancers [<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. ER stress can influence iron metabolism by increasing iron absorption, altering the regulation of iron storage, and modulating iron release, thereby promoting the occurrence of iron death. The occurrence of iron death is accompanied by the accumulation of lipid peroxides, which may damage the function of the ER, triggering an ER stress response [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>, <a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>]. This interaction plays a significant role in tumors such as colorectal cancer [<a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>] and liver cancer [<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>]. Jointly modulating iron death and ER stress responses may provide new strategies for cancer treatment and holds important potential in personalized therapy.</p>
<p id="Par51">Our findings reveal that anlotinib, not lenvatinib, induces ferroptosis in ATC cells by activating ER stress signaling.Previous studies, such as Ferrari et al., have demonstrated that lenvatinib exerts its anti-tumor effects primarily through apoptosis induction [<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a>]. In contrast, our results highlight a distinct mechanism of action for anlotinib, wherein reciprocal signaling between ER stress and ferroptosis plays a pivotal role. Specifically, anlotinib induces significant ROS and lipid peroxide accumulation by upregulating key ER stress markers, including ATF4, BiP, CHOP, and p-eIF2α. These findings provide mechanistic insights into the enhanced therapeutic efficacy of anlotinib, which combines anti-angiogenic effects with the ability to trigger ferroptosis. This dual mechanism likely explains its superiority over lenvatinib in treating ATC.</p>
<p id="Par52">The targeting of the ER stress-ferroptosis axis is emerging as a new strategy for cancer treatment, especially for solid tumors that are difficult to treat with traditional therapies [<a href="#CR45" class="usa-link" aria-describedby="CR45">45</a>]. Endoplasmic reticulum (ER) stress is a cellular response to environmental stress, and excessive ER stress alters iron homeostasis, activating ferroptosis-related genes (such as TFRC, FTH1) and proteins (such as ACSL4, GPX4). This leads to the accumulation of free iron, triggering ferroptosis, which results in cellular membrane damage and death. With increasing resistance to chemotherapy and radiotherapy, there is hope to reactivate the death mechanism of tumor cells by targeting the ER stress-ferroptosis axis, providing new directions for the development of anticancer drugs [<a href="#CR46" class="usa-link" aria-describedby="CR46">46</a>].</p>
<p id="Par53">Our study also highlights the potential clinical relevance of ferroptosis as a therapeutic target. Given ATC’s resistance to traditional apoptosis-based therapies, strategies that exploit ferroptosis may represent a breakthrough in overcoming therapeutic resistance. Future studies should explore combinatory approaches integrating ferroptosis inducers with conventional therapies to maximize clinical benefits.</p>
<p id="Par54">Certainly, our study has several limitations that warrant discussion. At the fundamental research level, the current investigation employs BALB/c nude mouse models which inherently lack a complete immune system. This biological constraint potentially compromises their ability to fully recapitulate authentic tumor microenvironment immune responses. Future investigations should prioritize exploring more physiologically relevant models, particularly patient-derived xenograft (PDX) models that better preserve tumor heterogeneity and therapeutic response profiles. Additionally, multi-species validation approaches should be implemented to enhance the translational reliability and broaden the applicability of our findings.</p>
<p id="Par55">From a clinical perspective, while anlotinib demonstrates greater clinical potential than Lenvatinib as a novel therapeutic agent, this preliminary observation requires rigorous validation through large-scale, multicenter clinical trials. To optimize therapeutic strategies, we propose two parallel research directions: First, systematic evaluation of combination therapies with ferroptosis inducers and Lenvatinib to potentially enhance treatment efficacy. Second, comprehensive clinical sample analysis should be conducted to validate the prognostic value of endoplasmic reticulum stress markers (e.g., CHOP, ATF4) and ferroptosis-associated proteins (e.g., GPX4, HO-1) in anlotinib-treated patients. These biomarkers may serve dual purposes as predictive indicators and mechanistic validators for targeted therapy optimization.</p></section><section id="Sec21"><h2 class="pmc_sec_title">Conclusion</h2>
<p id="Par56">This study identifies the reciprocal signaling between ER stress and ferroptosis as a critical mechanism underlying the superior efficacy of anlotinib in treating anaplastic thyroid carcinoma. By inducing ferroptosis, anlotinib provides a dual therapeutic approach that surpasses the anti-angiogenic effects of lenvatinib. Ferroptosis represents a promising therapeutic target for ATC, offering new avenues for developing effective treatment strategies for this highly aggressive cancer.</p></section><section id="Sec22"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12369195/bin/12935_2025_3947_MOESM1_ESM.png" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (6.5MB, png) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12369195/bin/12935_2025_3947_MOESM2_ESM.png" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (164.3KB, png) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/12369195/bin/12935_2025_3947_MOESM3_ESM.png" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 3</a><sup> (500.7KB, png) </sup>
</div></div></section></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ATC: </dt>
<dd><p id="Par6">Anaplastic thyroid carcinoma</p></dd>
<dt>ROS</dt>
<dd><p id="Par7">Reactive oxygen species</p></dd>
<dt>ER</dt>
<dd><p id="Par8">Endoplasmic reticulum</p></dd>
<dt>HE</dt>
<dd><p id="Par9">Hematoxylin and eosin</p></dd>
<dt>PTC</dt>
<dd><p id="Par10">Papillary thyroid cancer</p></dd>
<dt>Lipid ROS</dt>
<dd><p id="Par11">Lipid reactive oxygen species</p></dd>
<dt>TKIs</dt>
<dd><p id="Par12">Tyrosine kinase inhibitors</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>L.J. and T.Z. conceptualized and supervised the study. Y.G. drafted the manuscript. W.T., J.W., and L.J. conducted the in vitro experiments, while J.W. performed the in vivo experiments and immunohistochemical (IHC) assays. L.D. and W.H. contributed to data analysis and interpretation. All authors reviewed, edited, and approved the final manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research was supported by the following grants: Natural Science Foundation of Zhejiang Province (Grant Nos. LQ23H160050, Y22H168190). National Natural Science Foundation of China (Grant No. 82304521). Key Research and Development Program of Zhejiang Province (Grant No. 2024C03157). Science and Technology Foundation Project of the Guizhou Provincial Health Commission (Grant No. gzwkj2024-023).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethical approval</h3>
<p id="Par57">All animal experiments were approved by the Animal Care and Use Committee of Zhejiang Provincial People’s Hospital (Approval No. 20231205163258888328).</p></section><section id="FPar2"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par58">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div>
<div class="fn p" id="fn2"><p>Yehao Guo, Juyong Liang and Lingling Ding have contributed equally to this work.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Liehao Jiang, Email: jiangliehao@126.com.</p>
<p>Zhuo Tan, Email: tanzhuoyue@163.com.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Thyroid autoimmune disorders and cancer. Sem Cancer Biol. 202;64:135–46. 10.1016/j.semcancer.2019.05.019</cite> [<a href="https://doi.org/10.1016/j.semcancer.2019.05.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31158464/" class="usa-link">PubMed</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun. 2021;41(10):1037. 10.1002/cac2.12197.</cite> [<a href="https://doi.org/10.1002/cac2.12197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8504144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34288593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Qiu%20H,%20Cao%20S,%20Xu%20R.%20Cancer%20incidence,%20mortality,%20and%20burden%20in%20China:%20a%20time-trend%20analysis%20and%20comparison%20with%20the%20United%20States%20and%20United%20Kingdom%20based%20on%20the%20global%20epidemiological%20data%20released%20in%202020.%20Cancer%20Commun.%202021;41(10):1037.%2010.1002/cac2.12197." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Califano I, Smulever A, Jerkovich F, Pitoia F. Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease. Rev Endocr Metab Disord. 2024;25:123–47. 10.1007/s11154-023-09833-1.
</cite> [<a href="https://doi.org/10.1007/s11154-023-09833-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37648897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Califano%20I,%20Smulever%20A,%20Jerkovich%20F,%20Pitoia%20F.%20Advances%20in%20the%20management%20of%20anaplastic%20thyroid%20carcinoma:%20transforming%20a%20life-threatening%20condition%20into%20a%20potentially%20treatable%20disease.%20Rev%20Endocr%20Metab%20Disord.%202024;25:123%E2%80%9347.%2010.1007/s11154-023-09833-1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Haddad RI, Lydiatt WM, Ball DW, et al. Anaplastic thyroid carcinoma, version 2.2015. J Natl Compr Canc Netw. 2015;13:1140–50. 10.6004/jnccn.2015.0139.
</cite> [<a href="https://doi.org/10.6004/jnccn.2015.0139" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4986600/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26358798/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Haddad%20RI,%20Lydiatt%20WM,%20Ball%20DW,%20et%20al.%20Anaplastic%20thyroid%20carcinoma,%20version%202.2015.%20J%20Natl%20Compr%20Canc%20Netw.%202015;13:1140%E2%80%9350.%2010.6004/jnccn.2015.0139." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Maniakas A, Dadu R, Busaidy NL, et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000–2019. JAMA Oncol. 2020;6:1397–404. 10.1001/jamaoncol.2020.3362.
</cite> [<a href="https://doi.org/10.1001/jamaoncol.2020.3362" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7411939/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32761153/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maniakas%20A,%20Dadu%20R,%20Busaidy%20NL,%20et%20al.%20Evaluation%20of%20overall%20survival%20in%20patients%20with%20anaplastic%20thyroid%20carcinoma,%202000%E2%80%932019.%20JAMA%20Oncol.%202020;6:1397%E2%80%93404.%2010.1001/jamaoncol.2020.3362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Subbiah V, Kreitman RJ, Wainberg ZA, et al. Dabrafenib and trametinib treatment in patients with locally advanced or metastatic <em>BRAF</em> V600-mutant anaplastic thyroid cancer. J Clin Oncol. 2018;36:7–13. 10.1200/JCO.2017.73.6785.
</cite> [<a href="https://doi.org/10.1200/JCO.2017.73.6785" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5791845/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29072975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Subbiah%20V,%20Kreitman%20RJ,%20Wainberg%20ZA,%20et%20al.%20Dabrafenib%20and%20trametinib%20treatment%20in%20patients%20with%20locally%20advanced%20or%20metastatic%20BRAF%20V600-mutant%20anaplastic%20thyroid%20cancer.%20J%20Clin%20Oncol.%202018;36:7%E2%80%9313.%2010.1200/JCO.2017.73.6785." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Tong X, Tang R, Xiao M, et al. Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research. J Hematol Oncol. 2022;15:174. 10.1186/s13045-022-01392-3.
</cite> [<a href="https://doi.org/10.1186/s13045-022-01392-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9733270/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36482419/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tong%20X,%20Tang%20R,%20Xiao%20M,%20et%20al.%20Targeting%20cell%20death%20pathways%20for%20cancer%20therapy:%20recent%20developments%20in%20necroptosis,%20pyroptosis,%20ferroptosis,%20and%20cuproptosis%20research.%20J%20Hematol%20Oncol.%202022;15:174.%2010.1186/s13045-022-01392-3." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Liang C, Zhang X, Yang M, Dong X. Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 2019;31:e1904197. 10.1002/adma.201904197.
</cite> [<a href="https://doi.org/10.1002/adma.201904197" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31595562/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang%20C,%20Zhang%20X,%20Yang%20M,%20Dong%20X.%20Recent%20progress%20in%20ferroptosis%20inducers%20for%20cancer%20therapy.%20Adv%20Mater.%202019;31:e1904197.%2010.1002/adma.201904197." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Dixon SJ, Olzmann JA. The cell biology of ferroptosis. Nat Rev Mol Cell Biol. 2024;25:424–42. 10.1038/s41580-024-00703-5.
</cite> [<a href="https://doi.org/10.1038/s41580-024-00703-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12187608/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38366038/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dixon%20SJ,%20Olzmann%20JA.%20The%20cell%20biology%20of%20ferroptosis.%20Nat%20Rev%20Mol%20Cell%20Biol.%202024;25:424%E2%80%9342.%2010.1038/s41580-024-00703-5." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22:381–96. 10.1038/s41568-022-00459-0.
</cite> [<a href="https://doi.org/10.1038/s41568-022-00459-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10243716/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35338310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lei%20G,%20Zhuang%20L,%20Gan%20B.%20Targeting%20ferroptosis%20as%20a%20vulnerability%20in%20cancer.%20Nat%20Rev%20Cancer.%202022;22:381%E2%80%9396.%2010.1038/s41568-022-00459-0." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Friedmann Angeli JP, Krysko DV, Conrad M. Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 2019;19:405–14. 10.1038/s41568-019-0149-1.
</cite> [<a href="https://doi.org/10.1038/s41568-019-0149-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31101865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Friedmann%20Angeli%20JP,%20Krysko%20DV,%20Conrad%20M.%20Ferroptosis%20at%20the%20crossroads%20of%20cancer-acquired%20drug%20resistance%20and%20immune%20evasion.%20Nat%20Rev%20Cancer.%202019;19:405%E2%80%9314.%2010.1038/s41568-019-0149-1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Zhang J, Guo J, Yang N, et al. Endoplasmic reticulum stress-mediated cell death in liver injury. Cell Death Dis. 2022;13:1051. 10.1038/s41419-022-05444-x.
</cite> [<a href="https://doi.org/10.1038/s41419-022-05444-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9763476/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36535923/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20J,%20Guo%20J,%20Yang%20N,%20et%20al.%20Endoplasmic%20reticulum%20stress-mediated%20cell%20death%20in%20liver%20injury.%20Cell%20Death%20Dis.%202022;13:1051.%2010.1038/s41419-022-05444-x." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Kim R, Taylor D, Vonderheide RH, Gabrilovich DI. Ferroptosis of immune cells in the tumor microenvironment. Trends Pharmacol Sci. 2023;44:542–52. 10.1016/j.tips.2023.06.005.
</cite> [<a href="https://doi.org/10.1016/j.tips.2023.06.005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37380530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kim%20R,%20Taylor%20D,%20Vonderheide%20RH,%20Gabrilovich%20DI.%20Ferroptosis%20of%20immune%20cells%20in%20the%20tumor%20microenvironment.%20Trends%20Pharmacol%20Sci.%202023;44:542%E2%80%9352.%2010.1016/j.tips.2023.06.005." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Doll S, Proneth B, Tyurina YY, et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat Chem Biol. 2017;13:91–8. 10.1038/nchembio.2239.
</cite> [<a href="https://doi.org/10.1038/nchembio.2239" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5610546/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27842070/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Doll%20S,%20Proneth%20B,%20Tyurina%20YY,%20et%20al.%20ACSL4%20dictates%20ferroptosis%20sensitivity%20by%20shaping%20cellular%20lipid%20composition.%20Nat%20Chem%20Biol.%202017;13:91%E2%80%938.%2010.1038/nchembio.2239." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Viswanathan VS, Ryan MJ, Dhruv HD, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 2017;547:453–7. 10.1038/nature23007.
</cite> [<a href="https://doi.org/10.1038/nature23007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5667900/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28678785/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Viswanathan%20VS,%20Ryan%20MJ,%20Dhruv%20HD,%20et%20al.%20Dependency%20of%20a%20therapy-resistant%20state%20of%20cancer%20cells%20on%20a%20lipid%20peroxidase%20pathway.%20Nature.%202017;547:453%E2%80%937.%2010.1038/nature23007." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Zhang L, Feng Q, Wang J, et al. Molecular basis and targeted therapy in thyroid cancer: progress and opportunities. Biochimica et Biophysica Acta (BBA). 2023;1878: 188928. 10.1016/j.bbcan.2023.188928.</cite> [<a href="https://doi.org/10.1016/j.bbcan.2023.188928" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37257629/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20L,%20Feng%20Q,%20Wang%20J,%20et%20al.%20Molecular%20basis%20and%20targeted%20therapy%20in%20thyroid%20cancer:%20progress%20and%20opportunities.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%202023;1878:%20188928.%2010.1016/j.bbcan.2023.188928." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77:1745–70. 10.1007/s00018-019-03351-7.
</cite> [<a href="https://doi.org/10.1007/s00018-019-03351-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7190605/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31690961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lugano%20R,%20Ramachandran%20M,%20Dimberg%20A.%20Tumor%20angiogenesis:%20causes,%20consequences,%20challenges%20and%20opportunities.%20Cell%20Mol%20Life%20Sci.%202020;77:1745%E2%80%9370.%2010.1007/s00018-019-03351-7." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet. 2018;391:1163–73. 10.1016/S0140-6736(18)30207-1.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)30207-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29433850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kudo%20M,%20Finn%20RS,%20Qin%20S,%20et%20al.%20Lenvatinib%20versus%20sorafenib%20in%20first-line%20treatment%20of%20patients%20with%20unresectable%20hepatocellular%20carcinoma:%20a%20randomised%20phase%203%20non-inferiority%20trial.%20Lancet.%202018;391:1163%E2%80%9373.%2010.1016/S0140-6736(18)30207-1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Cheng Y, Chen J, Zhang W, et al. Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial. Nat Med. 2024;30:2967–76. 10.1038/s41591-024-03132-1.
</cite> [<a href="https://doi.org/10.1038/s41591-024-03132-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11485241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38992123/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cheng%20Y,%20Chen%20J,%20Zhang%20W,%20et%20al.%20Benmelstobart,%20anlotinib%20and%20chemotherapy%20in%20extensive-stage%20small-cell%20lung%20cancer:%20a%20randomized%20phase%203%20trial.%20Nat%20Med.%202024;30:2967%E2%80%9376.%2010.1038/s41591-024-03132-1." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Tahara M, Kiyota N, Yamazaki T, et al. Lenvatinib for anaplastic thyroid cancer. Front Oncol. 2017;7: 25. 10.3389/fonc.2017.00025.
</cite> [<a href="https://doi.org/10.3389/fonc.2017.00025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5331066/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28299283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tahara%20M,%20Kiyota%20N,%20Yamazaki%20T,%20et%20al.%20Lenvatinib%20for%20anaplastic%20thyroid%20cancer.%20Front%20Oncol.%202017;7:%2025.%2010.3389/fonc.2017.00025." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Schlumberger M, Tahara M, Wirth LJ, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. N Engl J Med. 2015;372:621–30. 10.1056/NEJMoa1406470.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1406470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25671254/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schlumberger%20M,%20Tahara%20M,%20Wirth%20LJ,%20et%20al.%20Lenvatinib%20versus%20placebo%20in%20radioiodine-refractory%20thyroid%20cancer.%20N%20Engl%20J%20Med.%202015;372:621%E2%80%9330.%2010.1056/NEJMoa1406470." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Li D, Chi Y, Chen X, et al. Anlotinib in locally advanced or metastatic medullary thyroid carcinoma: a randomized, double-blind phase IIB trial. Clin Cancer Res. 2021;27:3567–75. 10.1158/1078-0432.CCR-20-2950.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-20-2950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33832949/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Li%20D,%20Chi%20Y,%20Chen%20X,%20et%20al.%20Anlotinib%20in%20locally%20advanced%20or%20metastatic%20medullary%20thyroid%20carcinoma:%20a%20randomized,%20double-blind%20phase%20IIB%20trial.%20Clin%20Cancer%20Res.%202021;27:3567%E2%80%9375.%2010.1158/1078-0432.CCR-20-2950." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Wu J, Liang J, Liu R, et al. Autophagic blockade potentiates anlotinib-mediated ferroptosis in anaplastic thyroid cancer. Endocr Relat Cancer. 2023;30: e230036. 10.1530/ERC-23-0036.
</cite> [<a href="https://doi.org/10.1530/ERC-23-0036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10448565/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37283515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wu%20J,%20Liang%20J,%20Liu%20R,%20et%20al.%20Autophagic%20blockade%20potentiates%20anlotinib-mediated%20ferroptosis%20in%20anaplastic%20thyroid%20cancer.%20Endocr%20Relat%20Cancer.%202023;30:%20e230036.%2010.1530/ERC-23-0036." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Rao SN, Smallridge RC. Anaplastic thyroid cancer: an update. Best Pract Res Clin Endocrinol Metab. 2023;37: 101678. 10.1016/j.beem.2022.101678.
</cite> [<a href="https://doi.org/10.1016/j.beem.2022.101678" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35668021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rao%20SN,%20Smallridge%20RC.%20Anaplastic%20thyroid%20cancer:%20an%20update.%20Best%20Pract%20Res%20Clin%20Endocrinol%20Metab.%202023;37:%20101678.%2010.1016/j.beem.2022.101678." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Maniakas A, Zafereo M, Cabanillas ME. Anaplastic thyroid cancer: new horizons and challenges. Endocrinol Metab Clin North Am. 2022;51:391–401. 10.1016/j.ecl.2021.11.020.
</cite> [<a href="https://doi.org/10.1016/j.ecl.2021.11.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35662448/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maniakas%20A,%20Zafereo%20M,%20Cabanillas%20ME.%20Anaplastic%20thyroid%20cancer:%20new%20horizons%20and%20challenges.%20Endocrinol%20Metab%20Clin%20North%20Am.%202022;51:391%E2%80%93401.%2010.1016/j.ecl.2021.11.020." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Eelen G, Treps L, Li X, Carmeliet P. Basic and therapeutic aspects of angiogenesis updated. Circ Res. 2020;127:310–29. 10.1161/CIRCRESAHA.120.316851.
</cite> [<a href="https://doi.org/10.1161/CIRCRESAHA.120.316851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32833569/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Eelen%20G,%20Treps%20L,%20Li%20X,%20Carmeliet%20P.%20Basic%20and%20therapeutic%20aspects%20of%20angiogenesis%20updated.%20Circ%20Res.%202020;127:310%E2%80%9329.%2010.1161/CIRCRESAHA.120.316851." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Feng H, Jin Z, Liang J, et al. FOXK2 transcriptionally activating VEGFA induces apatinib resistance in anaplastic thyroid cancer through VEGFA/VEGFR1 pathway. Oncogene. 2021;40:6115–29. 10.1038/s41388-021-01830-5.
</cite> [<a href="https://doi.org/10.1038/s41388-021-01830-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34489549/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feng%20H,%20Jin%20Z,%20Liang%20J,%20et%20al.%20FOXK2%20transcriptionally%20activating%20VEGFA%20induces%20apatinib%20resistance%20in%20anaplastic%20thyroid%20cancer%20through%20VEGFA/VEGFR1%20pathway.%20Oncogene.%202021;40:6115%E2%80%9329.%2010.1038/s41388-021-01830-5." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Luis G, Godfroid A, Nishiumi S, et al. Tumor resistance to ferroptosis driven by Stearoyl-CoA Desaturase-1 (SCD1) in cancer cells and fatty acid biding Protein-4 (FABP4) in tumor microenvironment promote tumor recurrence. Redox Biol. 2021;43: 102006. 10.1016/j.redox.2021.102006.
</cite> [<a href="https://doi.org/10.1016/j.redox.2021.102006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8163990/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34030117/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Luis%20G,%20Godfroid%20A,%20Nishiumi%20S,%20et%20al.%20Tumor%20resistance%20to%20ferroptosis%20driven%20by%20Stearoyl-CoA%20Desaturase-1%20(SCD1)%20in%20cancer%20cells%20and%20fatty%20acid%20biding%20Protein-4%20(FABP4)%20in%20tumor%20microenvironment%20promote%20tumor%20recurrence.%20Redox%20Biol.%202021;43:%20102006.%2010.1016/j.redox.2021.102006." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Overcoming tyrosine kinase. inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade - PubMed. <a href="https://pubmed.ncbi.nlm.nih.gov/39423817/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/39423817/</a>. Accessed 22 Apr 2025.</cite> [<a href="https://doi.org/10.1016/j.ccell.2024.09.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39423817/" class="usa-link">PubMed</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Targeted therapy for drug-. tolerant persister cells after imatinib treatment for gastrointestinal stromal tumours - PubMed. <a href="https://pubmed.ncbi.nlm.nih.gov/34611306/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/34611306/</a>. Accessed 22 Apr 2025.</cite> [<a href="https://doi.org/10.1038/s41416-021-01566-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8608810/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34611306/" class="usa-link">PubMed</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Takahashi S, Kiyota N, Yamazaki T, et al. A phase II study of the safety and efficacy of lenvatinib in patients with advanced thyroid cancer. Future Oncol. 2019;15:717–26. 10.2217/fon-2018-0557.
</cite> [<a href="https://doi.org/10.2217/fon-2018-0557" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30638399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Takahashi%20S,%20Kiyota%20N,%20Yamazaki%20T,%20et%20al.%20A%20phase%20II%20study%20of%20the%20safety%20and%20efficacy%20of%20lenvatinib%20in%20patients%20with%20advanced%20thyroid%20cancer.%20Future%20Oncol.%202019;15:717%E2%80%9326.%2010.2217/fon-2018-0557." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Liang J, Jin Z, Kuang J, et al. The role of anlotinib-mediated EGFR blockade in a positive feedback loop of CXCL11-EGF-EGFR signalling in anaplastic thyroid cancer angiogenesis. Br J Cancer. 2021;125:390–401. 10.1038/s41416-021-01340-x.
</cite> [<a href="https://doi.org/10.1038/s41416-021-01340-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8328993/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34088989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liang%20J,%20Jin%20Z,%20Kuang%20J,%20et%20al.%20The%20role%20of%20anlotinib-mediated%20EGFR%20blockade%20in%20a%20positive%20feedback%20loop%20of%20CXCL11-EGF-EGFR%20signalling%20in%20anaplastic%20thyroid%20cancer%20angiogenesis.%20Br%20J%20Cancer.%202021;125:390%E2%80%93401.%2010.1038/s41416-021-01340-x." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Wirth LJ, Brose MS, Sherman EJ, et al. Open-label, single-arm, multicenter, phase II trial of lenvatinib for the treatment of patients with anaplastic thyroid cancer. J Clin Oncol. 2021;39:2359–66. 10.1200/JCO.20.03093.
</cite> [<a href="https://doi.org/10.1200/JCO.20.03093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8280094/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33961488/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wirth%20LJ,%20Brose%20MS,%20Sherman%20EJ,%20et%20al.%20Open-label,%20single-arm,%20multicenter,%20phase%20II%20trial%20of%20lenvatinib%20for%20the%20treatment%20of%20patients%20with%20anaplastic%20thyroid%20cancer.%20J%20Clin%20Oncol.%202021;39:2359%E2%80%9366.%2010.1200/JCO.20.03093." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Hao M, Jiang Y, Zhang Y, et al. Ferroptosis regulation by methylation in cancer. Biochimica et Biophysica Acta (BBA). 2023;1878: 188972. 10.1016/j.bbcan.2023.188972.</cite> [<a href="https://doi.org/10.1016/j.bbcan.2023.188972" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37634887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hao%20M,%20Jiang%20Y,%20Zhang%20Y,%20et%20al.%20Ferroptosis%20regulation%20by%20methylation%20in%20cancer.%20Biochimica%20et%20Biophysica%20Acta%20(BBA).%202023;1878:%20188972.%2010.1016/j.bbcan.2023.188972." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060–72. 10.1016/j.cell.2012.03.042.
</cite> [<a href="https://doi.org/10.1016/j.cell.2012.03.042" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3367386/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22632970/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dixon%20SJ,%20Lemberg%20KM,%20Lamprecht%20MR,%20et%20al.%20Ferroptosis:%20an%20iron-dependent%20form%20of%20nonapoptotic%20cell%20death.%20Cell.%202012;149:1060%E2%80%9372.%2010.1016/j.cell.2012.03.042." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Xu B, Fuchs T, Dogan S, et al. Dissecting anaplastic thyroid carcinoma: a comprehensive clinical, histologic, immunophenotypic, and molecular study of 360 cases. Thyroid. 2020;30:1505–17. 10.1089/thy.2020.0086.
</cite> [<a href="https://doi.org/10.1089/thy.2020.0086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7583343/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32284020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu%20B,%20Fuchs%20T,%20Dogan%20S,%20et%20al.%20Dissecting%20anaplastic%20thyroid%20carcinoma:%20a%20comprehensive%20clinical,%20histologic,%20immunophenotypic,%20and%20molecular%20study%20of%20360%20cases.%20Thyroid.%202020;30:1505%E2%80%9317.%2010.1089/thy.2020.0086." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Fagin JA, Krishnamoorthy GP, Landa I. Pathogenesis of cancers derived from thyroid follicular cells. Nat Rev Cancer. 2023;23:631–50. 10.1038/s41568-023-00598-y.
</cite> [<a href="https://doi.org/10.1038/s41568-023-00598-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10763075/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37438605/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fagin%20JA,%20Krishnamoorthy%20GP,%20Landa%20I.%20Pathogenesis%20of%20cancers%20derived%20from%20thyroid%20follicular%20cells.%20Nat%20Rev%20Cancer.%202023;23:631%E2%80%9350.%2010.1038/s41568-023-00598-y." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Bikas A, Ahmadi S, Pappa T, et al. Additional oncogenic alterations in RAS-driven differentiated thyroid cancers associate with worse clinicopathologic outcomes. Clin Cancer Res. 2023;29:2678–85. 10.1158/1078-0432.CCR-23-0278.
</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-23-0278" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10524472/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37260297/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bikas%20A,%20Ahmadi%20S,%20Pappa%20T,%20et%20al.%20Additional%20oncogenic%20alterations%20in%20RAS-driven%20differentiated%20thyroid%20cancers%20associate%20with%20worse%20clinicopathologic%20outcomes.%20Clin%20Cancer%20Res.%202023;29:2678%E2%80%9385.%2010.1158/1078-0432.CCR-23-0278." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Y X, W H, X S, et al. Ferroptosis: process and function. Cell Death Differ. 2016;23. 10.1038/cdd.2015.158.</cite> [<a href="https://doi.org/10.1038/cdd.2015.158" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5072448/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26794443/" class="usa-link">PubMed</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Lee Y-S, Lee D-H, Choudry HA, et al. Ferroptosis-induced endoplasmic reticulum stress: cross-talk between ferroptosis and apoptosis. Mol Cancer Res. 2018;16:1073–6. 10.1158/1541-7786.MCR-18-0055.
</cite> [<a href="https://doi.org/10.1158/1541-7786.MCR-18-0055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6030493/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29592897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee%20Y-S,%20Lee%20D-H,%20Choudry%20HA,%20et%20al.%20Ferroptosis-induced%20endoplasmic%20reticulum%20stress:%20cross-talk%20between%20ferroptosis%20and%20apoptosis.%20Mol%20Cancer%20Res.%202018;16:1073%E2%80%936.%2010.1158/1541-7786.MCR-18-0055." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>H L, S L, Q M, et al. Endoplasmic reticulum stress induced autophagy in cancer and its potential interactions with apoptosis and ferroptosis. Biochim Et Biophys Acta Mol Cell Res. 2025;1872. 10.1016/j.bbamcr.2024.119869.</cite> [<a href="https://doi.org/10.1016/j.bbamcr.2024.119869" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39490702/" class="usa-link">PubMed</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Jh K, Aj N, J L, et al. Involvement of bid in the crosstalk between ferroptotic agent-induced ER stress and TRAIL-induced apoptosis. J Cell Physiol. 2022;237. 10.1002/jcp.30863.</cite> [<a href="https://doi.org/10.1002/jcp.30863" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9691566/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35994698/" class="usa-link">PubMed</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>PERK Regulates the Sensitivity of Hepatocellular Carcinoma Cells to High-. LET Carbon Ions via either Apoptosis or Ferroptosis - PubMed. <a href="https://pubmed.ncbi.nlm.nih.gov/35069910/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/35069910/</a>. Accessed 22 Apr 2025.</cite> [<a href="https://doi.org/10.7150/jca.61622" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8771512/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35069910/" class="usa-link">PubMed</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Ferrari S, Bocci G, Di Desidero T, et al. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo. Oncol Rep. 2018. 10.3892/or.2018.6306.
</cite> [<a href="https://doi.org/10.3892/or.2018.6306" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29517103/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferrari%20S,%20Bocci%20G,%20Di%20Desidero%20T,%20et%20al.%20Lenvatinib%20exhibits%20antineoplastic%20activity%20in%20anaplastic%20thyroid%20cancer%20in%20vitro%20and%20in%20vivo.%20Oncol%20Rep.%202018.%2010.3892/or.2018.6306." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT.) to block stress-related ferroptosis - PubMed. <a href="https://pubmed.ncbi.nlm.nih.gov/36996941/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://pubmed.ncbi.nlm.nih.gov/36996941/</a>. Accessed 22 Apr 2025.</cite> [<a href="https://doi.org/10.1016/j.jhep.2023.03.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11332364/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36996941/" class="usa-link">PubMed</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>R W, Y Z, J W, et al. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci. 2021;17. 10.7150/ijbs.59404.</cite> [<a href="https://doi.org/10.7150/ijbs.59404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8326123/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34345202/" class="usa-link">PubMed</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369195/bin/12935_2025_3947_MOESM1_ESM.png" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (6.5MB, png) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369195/bin/12935_2025_3947_MOESM2_ESM.png" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 2</a><sup> (164.3KB, png) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12369195/bin/12935_2025_3947_MOESM3_ESM.png" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 3</a><sup> (500.7KB, png) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Cancer Cell International are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12935-025-03947-z"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12935_2025_Article_3947.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (9.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12369195/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12369195/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12369195%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12369195/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12369195/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12369195/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841645/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12369195/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841645/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12369195/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12369195/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="PHQj9DkfDYnFVyUdOOmAaRbJZGA5Jhb9VvfDmYFmKo2BdfrOLXlknN4qqFenEVGc">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
